Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AbbVie Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (146)
Cancellation by sponsor (90)
Prescription medicine registration (26)
Australian public assessment report (AusPar) (22)
Designation or determination (7)
Prescription medicine evaluation (6)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2026 (7)
2025 (30)
2024 (26)
2023 (26)
2022 (14)
2021 (14)
2020 (20)
2019 (24)
2018 (14)
2017 (29)
2016 (5)
2015 (19)
2014 (26)
2013 (4)
2012 (4)
2011 (4)
2010 (4)
2009 (4)
2008 (3)
2007 (1)
2006 (4)
2005 (4)
2002 (2)
2001 (1)
1999 (1)
1998 (1)
1997 (1)
1996 (1)
1994 (2)
1991 (5)

Search

Sponsor content

300 result(s) found, displaying 241 to 250

AusPAR: Adalimumab (rch)

23 December 2015

Australian public assessment report (AusPar)

Australian public assessment report for Adalimumab (rch)
Abbvie Pty Ltd - Needle, hypodermic (193150)

16 December 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Needle, hypodermic.
LUCRIN XL DEPOT 6-MONTH leuprorelin acetate 30 mg powder for injection prefilled dual-chamber syringe Cancelled under s30(1)(c )

4 September 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
Abbvie Pty Ltd - Lubricant, eye (188741)

1 September 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
Abbvie Pty Ltd - Lubricant, eye (187407)

8 August 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
HUMIRA adalimumab (rch) 40mg solution for injection pre-filled syringe Cancelled under s30(1)(c) of the Act

3 June 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
HUMIRA adalimumab (rch) 40mg solution for injection pre-filled pen Cancelled under s30(1)(c) of the Act

3 June 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
HUMIRA adalimumab (rch) 20mg solution for injection pre-filled syringe Cancelled under s30(1)(c) of the Act

3 June 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
BOTOX botulinum toxin type A purified neurotoxin complex 200U injection vial (172264)

2 March 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOTOX botulinum toxin type A purified neurotoxin complex 200U injection vial.
CHIROCAINE levobupivacaine hydrochloride 125mg/200mL solution for injection bag Cancelled under s30(1)(c )

12 March 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.